Topic: AS08-Treatment/AS08a-Current treatment options - Higher risk MDS: SINGLE-CENTER EXPERIENCE OF AZACITIDINE-VENETOCLAX IN SECONDARY ACUTE MYELOID LEUKEMIA (AML), ARISING FROM MYELODYSPLASTIC SYNDROME (MDS), MYELOPROLIFERATIVE NEOPLASM (MPN) OR MDS/MPN OVERLAP. (May 2023) - Halim, N.A. Abdul; Chan, T.W.; Wong, G.C.; Than, H.